Using a Multijunction Microfluidic Device To Inject Substrate into an Array of Preformed Plugs without Cross-Contamination: Comparing Theory and Experiments by Li, Liang et al.
Using a Multijunction Microfluidic Device To Inject Substrate into
an Array of Preformed Plugs without Cross-Contamination:
Comparing Theory and Experiments
Liang Li, James Q. Boedicker, and Rustem F. Ismagilov*
Department of Chemistry and Institute for Biophysical Dynamics, The University of Chicago, 929
East 57th Street, Chicago, Illinois 60637
Abstract
In this paper we describe a multijunction microfluidic device for the injection of a substrate into an
array of preformed plugs carried by an immiscible fluid in a microchannel. The device uses multiple
junctions to inject substrate into preformed plugs without synchronization of the flow of substrate
and the array of preformed plugs of reagent, which reduces cross-contamination of the plugs,
eliminates formation of small droplets of substrate, and allows a greater range of injection ratios
compared to that of a single T-junction. The device was based on a previously developed physical
model for transport that was here adapted to describe injection and experimentally verified. After
characterization, the device was applied to two biochemical assays, including evaluation of the
enzymatic activity of thrombin and determination of the coagulation time of human blood plasma,
which both provided reliable results. The reduction of cross-contamination and greater range of
injection ratios achieved by this device may improve the processes that involve addition and titration
of reagents into plugs, such as high-throughput screening of protein crystallization conditions.
In this paper we discuss a physical model of multiphase fluid flow1,2 during injection of a
stream into droplets and the use of this model to design and validate a multijunction
microfluidic injector for reliable addition of a substrate into an array of preformed plugs
containing reagents. This model has been presented previously for multiphase separation,1,2
and we used it to describe the related process of injecting reagents into droplets. Microfluidic
systems are attractive for miniaturizing laboratory techniques,3-8 and systems with multiphase
flows are useful for compartmentalizing reagents, enhancing mixing, and reducing dispersion
but require improved understanding and control.2,3,6,9-13 In plug-based systems, nanoliter or
picoliter droplets are formed within microchannels and carried by an immiscible fluid.14-16
Each plug contains multiple reagents and can act as a microreactor.13,17-21 For chemical and
biological reactions and analysis, multiple substrates and reagents must be introduced into
plugs. Introducing multiple reagents as a plug is forming can be done simply by relying on
laminar flow of several streams containing reagents.13 However, reliable addition of a
substrate to preformed plugs is more challenging.
Injection into preformed plugs may improve a number of processes such as protein
crystallization,22 synthesis of particles,23 biological assays,22 combinatorial chemistry,24
and chemical synthesis with one or multiple steps.25,26 In a T-junction, substrate is injected
from the side channel into preformed plugs traveling in the main channel (Figure 1A). Three
problems were identified for injection using a T-junction: (i) Cross-contamination between
plugs occurred when the substrate stream picked up reagents from a preformed plug and
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injected them into the subsequent plug in the array, a problem further described in the Results
and Discussion.22,24 “Blank plugs”, or buffer plugs, could be inserted between preformed
plugs to remove the contaminant from the substrate stream before the subsequent plug arrived,
thereby reducing cross-contamination but wasting substrate. (ii) Limited volumes of substrate
could be injected into each plug.24,27 (iii) At higher injection ratios, defined as the volume of
substrate injected divided by the original volume of the plug, substrate droplets formed between
preformed plugs.
To overcome the limitations present in the T-junction, we designed a multijunction injection
device (Figure 1B) and defined operation parameters for the device based a physical model of
multiphase fluid flow,1,2 which we adapted to describe the injector and experimentally
verified. To address problems i and ii, the device was designed with multiple long, narrow
hydrophilic side channels, which prevented cross-contamination while increasing the volume
of substrate that could be injected into each plug. To address problem iii, we used a physical
model1,2 to define the maximum working flow rate, Qmax, of the device. At a flow rate of
substrate below Qmax, substrate was reliably injected into preformed plugs without the
formation of substrate droplets. This device continuously injected substrate through any of the
side channels that were in contact with a preformed plug at a given time, eliminating the need
to synchronize the arrival of a plug at the side channels with the flow of substrate.
EXPERIMENTAL SECTION
Reagents and Solutions
Perfluoroperhydrophenanthrene (PPP) and 1H,1H,2H,2H-perfluorooctanol (PFO) were
obtained from Alfa Aesar (Ward Hill, MA). Substrate fluorescein diphosphate (FDP) and
thrombin from human plasma (1370 units/mg of protein) were obtained from Sigma-Aldrich
(St. Louis, MO). Substrate Boc-Asp (oBzl)-Pro-Arg-MCA (MCA IIa) and substrate Boc-Ile-
Gln-Gly-Arg-MCA (MCA Xa) were obtained from the Peptide Institute, Inc. (Osaka, Japan).
Alexin was obtained from Trinity Biotech Plc, Co. (Wicklow, Ireland). Human pooled plasma
(pooled normal) was obtained from George King Bio-medical, Inc. (Overland Park, KS). Red
dye solution (referred to as “red dye”) was made by mixing McCormick red food dye 1:100
(v/v) with Millipore water. Green dye solution (referred to as “green dye”) and viscous green
dye solution (referred to as “viscous green dye”) were made by mixing McCormick green food
dye 1:10 (v/v) with 24% (w/w) and 68% (w/w) glycerol/0.2 M KNO3 solution, respectively.
Fabrication of the Multijunction Device
Microfluidic devices were fabricated using rapid prototyping in poly(dimethylsiloxane)
(PDMS) from masters fabricated by using two-layer lithography as previously described.27
Microchannels were rendered hydrophobic and fluorophilic by using the silanization protocol
described previously.28 The parallel side channels were cut off and replaced with glass
capillaries (i.d. 100 μm, rendered hydrophilic by using a Plasma Prep II plasma cleaner).
Capillary wax was used to seal the connections to prevent leaking. A schematic drawing of
this device is shown in Figure 2.
Validation of the Physical Model
The experimental setup is shown in Figure 3.
Parameters and Solutions—PFO/PPP (1:10, v/v) was used as the carrier fluid. The
dynamic viscosity of the green dye was 0.0019 Pa s, and the surface tension between the carrier
fluid and the green dye was 0.0079 N/m. Flow rates of carrier fluid were tested in the range of
0.5-4.0 μL/min. Flow rates of the red dye and the green dye were kept the same as that of the
carrier fluid. For flow rates less than 2.0 μL/min, the array of red plugs was first formed at 4.0
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μL/min for the red dye and 4.0 μL/min for the carrier fluid. The array was driven by carrier
fluid at a flow rate of 1.0-4.0 μL/min, twice the testing flow rate (0.5-2.0 μL/min). The viscosity
was measured with a viscometer (Cannon, Inc., State College, PA), and the surface tension
was measured with the reported hanging drop method.28
Testing the Effect of Surface Tension (γ) at the Substrate/Carrier Interface on
Qmax—The PFO concentration in the carrier fluid was reduced to 1:500 (v/v), and the surface
tension between the green dye and the carrier fluid was 0.0202 N/m. Flow rates of carrier fluid
were tested in the range of 2.0-8.0 μL/min. Flow rates of the red and green dyes were kept the
same as that of the carrier fluid.
Testing the Effect of the Viscosity (μ) of the Substrate on Qmax—The dynamic
viscosity of the viscous green dye was 0.013 Pa s. The surface tension between the carrier fluid
and the viscous green dye was 0.0076 N/m. Flow rates of the carrier fluid were tested in the
range of 0.1-0.4 μL/min, and flow rates of the red and green dyes were kept the same as that
of the carrier fluid. The array of red plugs was formed as described above and driven by carrier
fluid at a flow rate of 0.2-0.8 μL/min, twice the testing flow rate (0.1-0.4 μL/min).
Test of Cross-Contamination
Color Change Reaction—Simple T-junction and multijunction injectors were used to inject
0.6 M KSCN solution into preformed plugs of 0.2 M Fe (NO3) 3 solution (Figure 2). The carrier
fluid was PFO/PPP (1:10, v/v). The flow rate of the array of preformed plugs was 2.0 μL/min
(1.0 μL/min for both the carrier fluid and Fe(NO3)3 solution), and that of the KSCN solution
was 1.0 μL/min.
Fluorescence Test—An array of alternating plugs with and without fluorescein was
generated by aspirating ∼27 nL of reagents in alternation with air bubbles ∼9 nL in volume.
The fluorescein solution was 0.10 mM fluorescein in 1× PBS buffer, and the non-fluorescein
solution was 1× PBS buffer. The carrier fluid was PFO/PPP (1:10, v/v). This array was aspirated
into a piece of Teflon tubing (o.d. 250 μm, i.d. 200 μm, length ∼8 cm). Capillary wax was used
to seal one end of the Teflon tubing containing the array to 30 gauge Teflon tubing connected
to a 10 μL syringe with a removable 27 gauge needle. The syringe and 30 gauge Teflon tubing
were filled with PFO/PPP (1:10, v/v).
The other end of the Teflon tubing containing the array was sealed to the inlet of the
multijunction device with capillary wax, and the array of plugs was injected with
nonfluorescent 1× PBS buffer (Supporting Information Figure S-1). The flow rate of the array
was 1.0 μL/min, and the flow rate of the buffer was 0.5 μL/min. The fluorescence intensity of
the resulting plugs was measured with a fluorescence microscopy systems a Leica DMI6000
microscope (Leica Microsystem, Germany) with a 10×/0.4 NA Leica objective and a
Hamamatsu ORCA-ER camera. A GFP filter was used to obtain fluorescent images of the
resulting plugs. The images were analyzed with the Metamorph imaging system, version 6.3r1.
Cross-contamination was quantified by determining the ratio of the intensity of the buffer plug
to the intensity of the fluorescein plug. The ratio was 1.28 × 10-3.
To detect any cross-contamination from manual aspiration, another array of plugs was made
in the same configuration. Without injection, the plugs were directly analyzed with
fluorescence microscopy in the same manner as above. The cross-contamination from manual
aspiration was 0.4 × 10-4. We concluded that the cross-contamination from injection was (1.28
× 10-3) - (0.4 × 10-4) = 1.2 × 10-3.
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Test of the Injection Ratio and Consistency
Plugs of red dye were formed in PFO/PPP (1:500, v/v) at flow rate of 10.0 μL/min for both the
red dye and the carrier fluid. The array of plugs was then driven by the carrier fluid at 4.0 μL/
min. We assumed the plugs were formed at Qred = 4 × 10/(10 + 10) = 2.0 μL/min. The green
dye was injected using the multijunction device. The flow rate of the green dye was changed
from 0 to 5.0 μL/min. For each flow rate, the plug length was measured.
Control Assay To Test the Enzymatic Activity of Three Substrates
An array of plugs of three substrates (150 μM substrate MCA IIa in 20 mM Tris, pH 7.3, 150
μM substrate MCA Xa in 20 mM Tris, pH 7.3, and 11 μM FDP in 1× PBS) was prepared in a
piece of Teflon tubing as in the fluorescence test. The array of plugs with a flow rate of 1.0
μL/min was injected with thrombin (0.8 μM in 20 mM Tris, pH 7.3) at 0.5 μL/min. The resulting
plugs were collected in a piece of Teflon tubing for fluorescence detection (Supporting
Information Figure S-2). The same fluorescent microscopy system used for the fluorescence
test was employed here, and GFP and DAPI filters were used to take images. The images were
analyzed with Metamorph.
Control Assay To Test Blood Clotting
An array of five sample plugs was prepared in a piece of Teflon tubing as in the fluorescence
test in the following sequence: (1) Tris buffer (20 mM Tris, 0.1 M NaCl, pH 7.4), (2) human
pooled plasma (PP), (3) thrombin (0.8 μM in 18 mM Tris and 0.09 M NaCl, pH 7.4), (4) PP +
alexin (1:1, v/v), (5) Tris buffer. The array was injected with the substrate containing 150 μM
MCA IIa, 40 mM CaCl2, 20 mM Tris, and 0.1 M NaCl, pH 7.4, using the multijunction device
(Figure 5A,B). The flow rate of the array was 0.5 μL/min, and the flow rate of the mixture was
0.25 μL/min. The resulting plugs were collected in a piece of Teflon tubing and monitored with
fluorescence microscopy for 60 min using a DAPI filter.
RESULTS AND DISCUSSION
Reducing Cross-Contamination
To reduce cross-contamination, we designed a multijunction device with three long, narrow
hydrophilic side channels. We previously found that creating a hydrophilic side channel made
injection more reliable, especially when the side channel was narrow.27 This modification was
achieved by replacing the PDMS side channel with a thin glass capillary. As narrow side
channels have also been found to reduce cross-contamination,27 we designed side channels to
be narrow and long by using a two-layer geometry (Figure 2). This decrease of cross-
contamination can be explained by an increase of the Peclet number (Pe). Pe is a dimensionless
parameter that represents the ratio of the rate of convection to the rate of diffusion. During
injection, convection injects the substrate into the plug, and diffusion of reagents out of the
plug causes contamination of the substrate stream (Figure 4A). Reducing the size of the side
channels increases the velocity U (m/s) of the substrate given the same volumetric flow rate.
Since Pe is defined as Ud/D, where U is the flow velocity of the substrate (m/s), d (m) is a
characteristic dimension, and D (m2/s) is the diffusion coefficient, increasing U results in an
increase of Pe, less effective diffusion, and reduced cross-contamination.
However, using narrow side channels limits the amount of substrate that could be injected into
the plugs. In a T-junction, the injection ratio was below 0.5.27 At higher injection ratios, the
substrate formed separate droplets between preformed plugs instead of being injected into a
plug. Small substrate droplets eventually coalesced with one of their neighboring plugs, making
the volume increase in the plugs inconsistent. This limitation made some applications difficult.
For example, protein crystallization, in principle, needs an injection ratio of 1, corresponding
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to equal volumes of precipitant and protein solution in a mixture. Coalescence of small substrate
droplets also made the time of reaction initiation difficult to define, limiting the applicability
of this technique to kinetic studies.
Eliminating the Formation of Substrate Droplets
To achieve a broader range of injection ratios while eliminating the formation of substrate
droplets, we wished to find conditions under which capillary forces would prevent injection
of the substrate into the carrier fluid through channels not in contact with a preformed plug
(and prevent formation of small substrate droplets). Using previously described equations,1,
2,29 we described the flow of the substrate into the main channel by considering the
competition between the capillary pressure (Pcap) and pressure drop (ΔPflow), expressed as eqs
1 and 2,
Pcap = (2γ cos θ) ∕ R (1)
ΔPflow = (8QμL ) ∕ (πR 4) (2)
respectively, where Pcap (Pa) is the capillary pressure exerted on the substrate by the carrier
fluid, γ (N/m) is the surface tension between the substrate and the carrier fluid, R (m) is the
radius of the circular side channels, θ (degree) is the angle between the substrate and the carrier
fluid, Q (m3/s) is the volumetric flow rate of the substrate, μ (Pa s) is the dynamic viscosity of
the substrate, L (m) is the length of the side channel, and ΔPflow is the pressure drop along the
side channels with length L (m) (Figure 1B). When a preformed plug is in contact with the
substrate (Figure 1B, right inset), Pcap exerted on the substrate is reduced and injection
proceeds. When no plug is present at the junction, capillary pressure prevents injection of
substrate into the carrier fluid (Figure 1B, left inset), which can be expressed by
Pcap > ΔPflow (3)
We have assumed that Pcap is small at junctions where a plug is present and can be neglected;
if this is not the case, ΔPcap should be used in eq 3. Equation 3 also requires that a preformed
plug is always in contact with at least one side channel, which can only be achieved when the
distance between two adjacent plugs is smaller than the distance between the two outer side
channels. Equation 3 assumes that ΔPflow is much higher than the pressure drop along a fluid
path connecting the substrate inlet to the entrances of the side channels. Equation 3 also assumes
that the system operates at a low value of the capillary number16,30 and that injection is not
limited by the drainage of the carrier fluid between the substrate and the preformed plug.
Equation 3 predicts a maximum flow rate of substrate at which ΔPflow can still be overcome
by Pcap and formation of substrate droplets is prevented, Qmax (m3/s). Similar to the largest
working flow rate of the multiphase separation device,1 this maximum flow is given by
Qmax = (πR 3γ) ∕ (4μL ) (4)
when cos θ = 1. We tested the influence of the μ and γ parameters on Qmax in a device with
R = 50 μm and L = 14000 μm (Figure 3). We used eq 4 to predict Qmax. No adjustable parameters
were used to make the predictions. Experimental values were obtained by “bracketing”:
changing Q to identify the highest Q with reliable injection and the lowest Q that resulted in
undesirable formation of small droplets. The predicted value of Qmax always fell within the
“bracketed” range, confirming eq 4. Also, both predicted and experimental values behaved as
expected: Qmax increased as γ was increased, and Qmax decreased as μ was increased (Figure
3).
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Therefore, for given device dimensions, substrate, and carrier fluid, a certain maximum
substrate flow rate, Qmax, exists, below which reliable injection occurs without the formation
of small substrate droplets. To operate this device, an array of preformed plugs, with the
distance between adjacent plugs no greater than the distance between the two outer side
channels, is flowed into the device. Substrate is continuously injected at Q < Qmax through any
of the side channels that are in contact with a preformed plug at a given time. There is no need
to synchronize the arrival of a plug at the side channels with the flow of substrate, making
injection reliable during continuous operation of the device.
Characterizing Cross-Contamination
We tested this device for cross-contamination, injection consistency, and the range of injection
ratios. A simple T-junction and the multijunction device were both tested with a color-change
reaction. Reduced contamination and more reliable injection were observed in the
multijunction device compared to the T-junction (Figure 4). Cross-contamination in the
multijunction device was further quantified by a fluorescence experiment. Alternating plugs
with and without fluorescein, a fluorescent dye, were aspirated into a piece of Teflon tubing
to form an array. This array was injected with nonfluorescent buffer using the multijunction
device. Any cross-contamination from the fluorescein plug would have been injected into the
next buffer plug, making the buffer plug fluoresce. Therefore, the ratio of the fluorescence
intensity of the injected buffer plug to that of the injected fluorescein plug quantifies the total
cross-contamination through the three side channels (Supporting Information Figure S-1).
Using quantitative microscopy, we determined cross-contamination to be about 0.1% for the
multijunction device, much less than that of the T-junction (up to ∼10%).24
Characterizating Injection Consistency and Injection Ratios
In tests to evaluate the injection consistency and the range of injection ratios, an array of red
dye plugs was generated and subsequently injected with green dye (Figure 3A). The
multijunction device injected substrate over a 0-1.5 range of injection ratios (Supporting
Information Figure S-3), an increase in range as compared to that of the T-junction (typically
up to ∼0.3).27 The injection ratio (ν) was defined as the relative amount of green dye injected
into the red plugs and was semiquantitatively obtained by measuring the length of the plugs
after injection. The injection ratio was calculated as ν = (L - L0)/L0, where L is the length of
the plugs after injection at a certain flow rate and L0 is the original length of the plug. The plug
length with no substrate flow (injection flow rate of 0 μL/min) was used as the original length.
On the basis of mass conservation, the theoretical injection ratio νtheo is specified as νtheo =
Qgreen/Qred, where Qgreen is the flow rate of the green dye and Qred is the flow rate of the red
dye (2.0 μL/min). We found that the injection ratio could be controlled by flow rates and could
go up to 1.5 (Supporting Information Figure S-3). We also found that the amount of substrate
injected into each preformed plug was consistent. The coefficient of variation (CV) was below
3% on the basis of the measurements of six consecutive plugs.
Demonstrating Potential Applications of the Multijunction Device
We performed two control assays to demonstrate potential applications of the injection device.
To ensure reliable injection, we chose flow rates of the substrate stream well below the
estimated Qmax. To check the reliability of the device for performing enzymatic activity assays,
we evaluated the activity of thrombin by using three fluorogenic substrates: MCA IIa, MCA
Xa, and a negative control, FDP. Thrombin (IIa) is a protease formed during the clotting of
blood that catalyzes the cleavage of peptides. When thrombin induces cleavage of a peptide
from MCA IIa or MCA Xa, cumarin dye is released, resulting in an increase of fluorescence.
31 Thrombin cleaves MCA IIa 1000 times more rapidly than MCA Xa.31 An array of
plugs22 of the three substrates was injected with thrombin by using the multijunction device.
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The resulting plugs were collected in a piece of Teflon tubing for fluorescence detection
(Supporting Information Figure S-2). A significant fluorescence increase was only detected in
the plug of MCA IIa, indicating that the device was reliable and did not give false positive
results.
To assess the capability of the device for handling complex fluids, we used the device to test
the clotting time of human blood plasma. Production of thrombin is accelerated in the presence
of clotting activators such as alexin. We injected the substrate MCA IIa into an array of five
plugs in the following sequence: (1) Tris buffer, (2) human PP, (3) thrombin, (4) PP + alexin,
and (5) Tris buffer, shown in Figure 5A. We monitored the resulting plugs with fluorescent
microscopy for 60 min (Figure 5B). Plug 1 did not show an increase of fluorescence intensity.
Plug 2 provided the background clotting time (15 min) under these experimental conditions.
Plugs 3 and 4 showed a significant increase in fluorescence relative to that of plug 2 within 5
min, confirming that addition of alexin shortened the clotting time. In plug 5, a very slow
increase of fluorescence was detected, most likely due to cross-contamination from plug 4.
After 1 h of incubation, the intensity in plug 5 was 5 times lower than the average intensity of
plugs 3 and 4. Intensity profiles for all five plugs over time are shown in Figure 5C. While
cross-contamination tests predicted that only 0.1% of plasma and alexin should be transferred
to plug 5, even a small amount of contamination could lead to an observable fluorescent signal,
because thrombin is an enzyme. This result emphasizes the importance of reducing cross-
contamination.
CONCLUSIONS
The multijunction device described in this paper improves upon the previously reported T-
junction by significantly reducing cross-contamination and providing a wider range of injection
ratios. The physical model of transport1,2 we have used to design the multijunction device was
experimentally verified and shown to predict the maximum flow rate, Qmax, to within a factor
of 2. Enzymatic reactions are especially sensitive to cross-contamination and would benefit
the most from this approach. A wider range of accessible injection ratios means that this device
could be applied to titrations and assays that require a wide range in volume of substrate inputs,
such as protein crystallization trials. This technology is also applicable to complex biological
fluids such as blood. These improvements should lead to new applications of microfluidic
assays that require screening multiple conditions in nanoliter volumes. We are currently
applying this technology to the crystallization of membrane proteins32 which are available
only in small quantities and are challenging to handle.
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Figure 1.
Schematic drawings of two microfluidic devices used to inject a substrate into an array of
preformed plugs: (A) simple T-junction device; (B) multijunction injector described in this
paper. Parameters for the physical model, including ΔPflow and Pcap, are shown (see the text
for details).
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Figure 2.
Key features in the fabrication of the multijunction device. The parallel side channels of a
PDMS device, made by using two-layer lithography, were replaced with glass capillaries to
make the side channels hydrophilic.
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Figure 3.
Experimental validation of Qmax predicted by the physical model. Predicted Qmax values are
shown in red in larger font, and experimentally observed values of Q at which the transition
occurs from successful injection to formation of small droplets are shown in black. (A)
Schematic drawing of the experimental setup. Plugs of red dye were formed in a T-junction,
and green dye was injected using the multijunction device. (B-D) Substrate solution (green
dye) was injected into preformed plugs at flow rates below (left column) and above (right
column) the predicted Qmax for various experimental conditions. Formation of small droplets
of substrate solution was prevented only when the flow rate of substrate was below Qmax (see
the text for details). (E) A diagram showing injection patterns for experiments B, C, and D.
Solid circles indicate flow rates yielding reliable injection at given γ/μ values; open triangles
indicate flow rates yielding nonreliable injection at given γ/μ values; red squares indicate
predicted Qmax at given γ/μ values. The shaded region indicates the range of flow rates resulting
in reliable injection for specific values of γ/μ.
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Figure 4.
Tests for cross-contamination with a color-change reaction. Injecting KSCN solution (clear)
into preformed Fe(NO3)3 plugs (clear) resulted in red plugs (Fe(SCN)3 solution). (A) The T-
junction caused cross-contamination: the red solution remained in the side channel after
injection. The side channel (vertical) was a glass capillary with an i.d. of 200 μm. The main
channel (horizontal) was a 200 μm × 200 μm PDMS channel. (B) The multijunction device
reduced cross-contamination: no red solution was observed in the side channels (glass
capillaries, 100 μm i.d.) after a plug passed by. The main channel was a 200 μm × 250 μm
PDMS channel that increased to 250 μm × 250 μm after the junctions.
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Figure 5.
A control blood assay performed with the multijunction device. (A) Schematic drawing of the
experimental setup. Substrate MCA IIa was injected into five preformed plugs separated by
air bubbles. The five plugs were formed in the order (1, open brown circles) Tris buffer, (2,
solid red triangles) human PP, (3, solid yellow squares) thrombin, (4, open inverted triangles)
PP + alexin, and (5, open blue triangles) Tris buffer. (B) Fluorescent images of the five resulting
plugs taken at the time point of 20 min, scale bar 200 μm. (C) Profiles of fluorescence intensity
for five plugs in the assay. Fluorescent images were collected under the same conditions, and
the fluorescence intensity was normalized the same way in all images.
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